240 related articles for article (PubMed ID: 22961688)
1. Reduced hepatic stellate cell expression of Kruppel-like factor 6 tumor suppressor isoforms amplifies fibrosis during acute and chronic rodent liver injury.
Ghiassi-Nejad Z; Hernandez-Gea V; Woodrell C; Lang UE; Dumic K; Kwong A; Friedman SL
Hepatology; 2013 Feb; 57(2):786-96. PubMed ID: 22961688
[TBL] [Abstract][Full Text] [Related]
2. NEAT1 accelerates the progression of liver fibrosis via regulation of microRNA-122 and Kruppel-like factor 6.
Yu F; Jiang Z; Chen B; Dong P; Zheng J
J Mol Med (Berl); 2017 Nov; 95(11):1191-1202. PubMed ID: 28864835
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
[TBL] [Abstract][Full Text] [Related]
4. Enhanced hepatocarcinogenesis in mouse models and human hepatocellular carcinoma by coordinate KLF6 depletion and increased messenger RNA splicing.
Vetter D; Cohen-Naftaly M; Villanueva A; Lee YA; Kocabayoglu P; Hannivoort R; Narla G; M Llovet J; Thung SN; Friedman SL
Hepatology; 2012 Oct; 56(4):1361-70. PubMed ID: 22535637
[TBL] [Abstract][Full Text] [Related]
5. Deactivation of hepatic stellate cells during liver fibrosis resolution in mice.
Troeger JS; Mederacke I; Gwak GY; Dapito DH; Mu X; Hsu CC; Pradere JP; Friedman RA; Schwabe RF
Gastroenterology; 2012 Oct; 143(4):1073-83.e22. PubMed ID: 22750464
[TBL] [Abstract][Full Text] [Related]
6. Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma.
Yea S; Narla G; Zhao X; Garg R; Tal-Kremer S; Hod E; Villanueva A; Loke J; Tarocchi M; Akita K; Shirasawa S; Sasazuki T; Martignetti JA; Llovet JM; Friedman SL
Gastroenterology; 2008 May; 134(5):1521-31. PubMed ID: 18471523
[TBL] [Abstract][Full Text] [Related]
7. Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease.
Bechmann LP; Gastaldelli A; Vetter D; Patman GL; Pascoe L; Hannivoort RA; Lee UE; Fiel I; Muñoz U; Ciociaro D; Lee YM; Buzzigoli E; Miele L; Hui KY; Bugianesi E; Burt AD; Day CP; Mari A; Agius L; Walker M; Friedman SL; Reeves HL
Hepatology; 2012 Apr; 55(4):1083-93. PubMed ID: 22095588
[TBL] [Abstract][Full Text] [Related]
8. A functional role for KLF6-SV1 in lung adenocarcinoma prognosis and chemotherapy response.
DiFeo A; Feld L; Rodriguez E; Wang C; Beer DG; Martignetti JA; Narla G
Cancer Res; 2008 Feb; 68(4):965-70. PubMed ID: 18250346
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin α(V)β(3) engagement and PI3K/pAkt/NFκB signaling.
Urtasun R; Lopategi A; George J; Leung TM; Lu Y; Wang X; Ge X; Fiel MI; Nieto N
Hepatology; 2012 Feb; 55(2):594-608. PubMed ID: 21953216
[TBL] [Abstract][Full Text] [Related]
10. The role of KLF6 and its splice variants in cancer therapy.
DiFeo A; Martignetti JA; Narla G
Drug Resist Updat; 2009; 12(1-2):1-7. PubMed ID: 19097929
[TBL] [Abstract][Full Text] [Related]
11. A small interfering RNA targeting the KLF6 splice variant, KLF6-SV1, as gene therapy for gastric cancer.
Chen H; Chen L; Sun L; Zhen H; Li X; Zhang Q
Gastric Cancer; 2011 Oct; 14(4):339-52. PubMed ID: 21538018
[TBL] [Abstract][Full Text] [Related]
12. Identification of miRNAs that specifically target tumor suppressive KLF6-FL rather than oncogenic KLF6-SV1 isoform.
Liang WC; Wang Y; Xiao LJ; Wang YB; Fu WM; Wang WM; Jiang HQ; Qi W; Wan DC; Zhang JF; Waye MM
RNA Biol; 2014; 11(7):845-54. PubMed ID: 24921656
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-30 Protects Against Carbon Tetrachloride-induced Liver Fibrosis by Attenuating Transforming Growth Factor Beta Signaling in Hepatic Stellate Cells.
Tu X; Zheng X; Li H; Cao Z; Chang H; Luan S; Zhu J; Chen J; Zang Y; Zhang J
Toxicol Sci; 2015 Jul; 146(1):157-69. PubMed ID: 25912033
[TBL] [Abstract][Full Text] [Related]
14. KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis.
Narla G; DiFeo A; Fernandez Y; Dhanasekaran S; Huang F; Sangodkar J; Hod E; Leake D; Friedman SL; Hall SJ; Chinnaiyan AM; Gerald WL; Rubin MA; Martignetti JA
J Clin Invest; 2008 Aug; 118(8):2711-21. PubMed ID: 18596922
[TBL] [Abstract][Full Text] [Related]
15. Biology of Krüppel-like factor 6 transcriptional regulator in cell life and death.
Andreoli V; Gehrau RC; Bocco JL
IUBMB Life; 2010 Dec; 62(12):896-905. PubMed ID: 21154818
[TBL] [Abstract][Full Text] [Related]
16. Ablation of serum response factor in hepatic stellate cells attenuates liver fibrosis.
Kong M; Hong W; Shao Y; Lv F; Fan Z; Li P; Xu Y; Guo J
J Mol Med (Berl); 2019 Nov; 97(11):1521-1533. PubMed ID: 31435710
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte and stellate cell deletion of liver fatty acid binding protein reveals distinct roles in fibrogenic injury.
Newberry EP; Xie Y; Lodeiro C; Solis R; Moritz W; Kennedy S; Barron L; Onufer E; Alpini G; Zhou T; Blaner WS; Chen A; Davidson NO
FASEB J; 2019 Mar; 33(3):4610-4625. PubMed ID: 30576225
[TBL] [Abstract][Full Text] [Related]
18. Energy restriction-mimetic agents induce apoptosis in prostate cancer cells in part through epigenetic activation of KLF6 tumor suppressor gene expression.
Chen CH; Huang PH; Chu PC; Chen MC; Chou CC; Wang D; Kulp SK; Teng CM; Wang Q; Chen CS
J Biol Chem; 2011 Mar; 286(12):9968-76. PubMed ID: 21282102
[TBL] [Abstract][Full Text] [Related]
19. In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma.
Narla G; Kremer-Tal S; Matsumoto N; Zhao X; Yao S; Kelley K; Tarocchi M; Friedman SL
Oncogene; 2007 Jun; 26(30):4428-34. PubMed ID: 17297474
[TBL] [Abstract][Full Text] [Related]
20. Exosome-mediated activation of toll-like receptor 3 in stellate cells stimulates interleukin-17 production by γδ T cells in liver fibrosis.
Seo W; Eun HS; Kim SY; Yi HS; Lee YS; Park SH; Jang MJ; Jo E; Kim SC; Han YM; Park KG; Jeong WI
Hepatology; 2016 Aug; 64(2):616-31. PubMed ID: 27178735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
